Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
VL-SE-01 is an investigational product being evaluated in a randomized, double-blind, placebo-controlled clinical trial for safety, pharmacokinetics, and efficacy in healthy participants. The trial assesses effects on metabolic, liver, renal, hormonal, and cardiovascular markers, alongside stress response and menstrual cycle regularity. The mechanism of action and chemical composition have not been disclosed publicly. The study is sponsored by Vedic Lifesciences, which suggests that it may be a dietary supplement or novel nutraceutical candidate intended to impact general wellness markers such as blood glucose, liver function, renal function, inflammation, hormone profiles, and stress.[1][3][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on VL-SE-01.